Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
User-agent: * |
Title | Vrex Therapeutics, Inc. - Oncolytic Virus, Immuno |
Description | Systemic Destruction of Solid Developing the worlds most powerful, yet safest, oncolytic viruses based on a proven herpes simplex virus 1 |
Keywords | N/A |
WebSite | vrextherapeutics.com |
Host IP | 160.153.136.3 |
Location | United States |
Site | Rank |
US$486,913
Last updated: 2022-11-04 07:23:46
vrextherapeutics.com has Semrush global rank of 21,737,579. vrextherapeutics.com has an estimated worth of US$ 486,913, based on its estimated Ads revenue. vrextherapeutics.com receives approximately 56,183 unique visitors each day. Its web server is located in United States, with IP address 160.153.136.3. According to SiteAdvisor, vrextherapeutics.com is safe to visit. |
Purchase/Sale Value | US$486,913 |
Daily Ads Revenue | US$450 |
Monthly Ads Revenue | US$13,484 |
Yearly Ads Revenue | US$161,805 |
Daily Unique Visitors | 3,746 |
Note: All traffic and earnings values are estimates. |
Host | Type | TTL | Data |
vrextherapeutics.com. | A | 599 | IP: 160.153.136.3 |
vrextherapeutics.com. | NS | 3600 | NS Record: ns32.domaincontrol.com. |
vrextherapeutics.com. | NS | 3600 | NS Record: ns31.domaincontrol.com. |
vrextherapeutics.com. | MX | 3600 | MX Record: 0 vrextherapeutics-com.mail.protection.outlook.com. |
vrextherapeutics.com. | TXT | 3600 | TXT Record: NETORGFT5814747.onmicrosoft.com |
vrextherapeutics.com. | TXT | 3600 | TXT Record: v=spf1 include:spf.protection.outlook.com -all |
Home Our Science Our Pipeline Partnering Founding Team Scientific Advisory Board History Home Our Science Our Pipeline Partnering About Us Founding Team Scientific Advisory Board History Home Our Science Our Pipeline Partnering Systemic Destruction of Solid Tumors Our mission at VREX Therapeutics is the advancement of groundbreaking oncolytic immunotherapies that improve the treatment of intractable local and metastasized solid tumor cancers. Our novel SOVI platform has been uniquely engineered to attack the complexity of cancer at multiple points of intervention. In fact, we have the only oncolytic immunotherapy platform with intelligent control of both viral replication and transcription of immunomodulators within the local tumor microenvironment. SOVI is also specifically modified to drive robust innate and tumor specific adaptive immune response, no matter the therapeutic payload. We believe these unique aspect of SOVI will translate into more effective systemic treatments against |
HTTP/1.1 301 Moved Permanently location: https://vrextherapeutics.com/ Vary: Accept-Encoding Server: DPS/1.13.2 X-SiteId: 4000 Set-Cookie: dps_site_id=4000; path=/ Date: Wed, 06 Apr 2022 09:13:03 GMT Connection: keep-alive Keep-Alive: timeout=5 HTTP/2 404 content-type: text/html;charset=utf-8 content-length: 964 vary: Accept-Encoding server: DPS/1.13.2 x-siteid: 4000 set-cookie: dps_site_id=4000; path=/; secure date: Wed, 06 Apr 2022 09:13:03 GMT |
Domain Name: VREXTHERAPEUTICS.COM Registry Domain ID: 2443096425_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.godaddy.com Registrar URL: http://www.godaddy.com Updated Date: 2021-10-13T16:05:51Z Creation Date: 2019-10-13T01:57:12Z Registry Expiry Date: 2022-10-13T01:57:12Z Registrar: GoDaddy.com, LLC Registrar IANA ID: 146 Registrar Abuse Contact Email: abuse@godaddy.com Registrar Abuse Contact Phone: 480-624-2505 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: NS31.DOMAINCONTROL.COM Name Server: NS32.DOMAINCONTROL.COM DNSSEC: unsigned >>> Last update of whois database: 2022-04-06T09:30:44Z <<< |